Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

2.600

-0.020 (-0.76%)

At close: Jun 29, 2026, 4:00 PM EDT

2.600

0.00 (0.00%)

Pre-market: Jun 30, 2026, 4:04 AM EDT

Anavex Life Sciences Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Selling, General & Admin	12.8	13.82	11.04	12.05	13.07	9.02
Research & Development	36.46	37.59	41.84	43.72	37.92	32.98
Total Operating Expenses	49.25	51.41	52.88	55.76	50.99	42
Operating Income	-44.6	-51.41	-52.88	-55.76	-50.99	-42
Interest Income	4.66	5.36	9.69	9.26	4.27	4.63
Interest Expense	-	-	-	-0.96	-	-
Other Non-Operating Income (Expense)	1.13	-0.33	0.19	-0.04	-0.9	-0.27
Total Non-Operating Income (Expense)	5.79	5.03	9.88	8.26	3.37	4.36
Pretax Income	-5.66	-46.38	-43	-47.51	-47.62	-37.64
Provision for Income Taxes	0.04	-	-	-	-	-
Net Income	-5.68	-46.38	-43	-47.51	-47.62	-37.64
Net Income to Common	-5.68	-46.38	-43	-47.51	-47.62	-37.64
Shares Outstanding (Basic)	86	85	83	80	77	70
Shares Outstanding (Diluted)	86	85	83	80	77	70
Shares Change (YoY)	2.61%	2.18%	4.61%	3.74%	10.18%	19.95%
EPS (Basic)	-0.46	-0.54	-0.52	-0.60	-0.62	-0.54
EPS (Diluted)	-0.46	-0.54	-0.52	-0.60	-0.62	-0.54
Free Cash Flow	-34.08	-39.04	-30.81	-27.79	-24.24	-30.38
Free Cash Flow Per Share	-0.39	-0.46	-0.37	-0.35	-0.32	-0.44
EBITDA	-44.6	-51.41	-52.88	-55.76	-50.99	-42
EBIT	-44.6	-51.41	-52.88	-55.76	-50.99	-42
Effective Tax Rate	-0.64%	0.00%	0.00%	0.00%	0.00%	0.00%

SEC Filings: 10-K · 10-Q